• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PEG 化脂质体在体外猪眼完整玻璃体中的扩散动力学:荧光相关光谱和生物分布研究。

The diffusion dynamics of PEGylated liposomes in the intact vitreous of the ex vivo porcine eye: A fluorescence correlation spectroscopy and biodistribution study.

机构信息

Department for Micro- and Nanotechnology, Technical University of Denmark, Building 345C, 2800 Kgs. Lyngby, Denmark.

Department of Biochemistry and Molecular Biology, University of Southern Denmark, Campusvej 55, 5230 Odense M, Denmark.

出版信息

Int J Pharm. 2017 Apr 30;522(1-2):90-97. doi: 10.1016/j.ijpharm.2017.03.003. Epub 2017 Mar 4.

DOI:10.1016/j.ijpharm.2017.03.003
PMID:28267579
Abstract

The diffusion dynamics of nanocarriers in the vitreous and the influence of nanocarrier physicochemical properties on these dynamics is an important aspect of the efficacy of intravitreal administered nanomedicines for the treatment of posterior segment eye diseases. Here we use fluorescence correlation spectroscopy (FCS) to determine liposome diffusion coefficients in the intact vitreous (D) of ex vivo porcine eyes using a modified Miyake-Apple technique to minimize the disruption of the vitreous fine structure. We chose to investigate whether the zeta potential of polyethylene glycol functionalized (i.e. PEGylated) liposomes altered liposome in situ diffusion dynamics in the vitreous. Non-PEGylated cationic nanocarriers have previously shown little to no diffusion in the vitreous, whilst neutral and anionic have shown diffusion. The liposomes investigated had diameters below 150nm and zeta potentials ranging from -20 to +12mV. We observed that PEGylated cationic liposomes had significantly lower D values (1.14μms) than PEGylated neutral and anionic liposomes (2.78 and 2.87μms). However, PEGylated cationic liposomes had a similar biodistribution profile across the vitreous to the other systems. These results show that PEGylated cationic liposomes with limited cationic charge can diffuse across the vitreous and indicate that the vitreous as a barrier to nanocarriers (Ø<500nm) is more complicated than simply an electrostatic barrier as previously suggested.

摘要

纳米载体在玻璃体内的扩散动力学以及纳米载体理化性质对这些动力学的影响是玻璃体内给药的纳米药物治疗后节段眼病疗效的一个重要方面。在这里,我们使用荧光相关光谱(FCS)来确定使用 Miyake-Apple 技术(以最小化玻璃体精细结构的破坏)修饰后的离体猪眼玻璃体(D)中脂质体的扩散系数。我们选择研究聚乙二醇(即 PEG)功能化的脂质体的 ζ 电位是否改变了脂质体在玻璃体中的原位扩散动力学。先前的研究表明,非 PEG 化的阳离子纳米载体在玻璃体内几乎没有扩散,而中性和阴离子则有扩散。研究的脂质体直径小于 150nm,ζ 电位范围为-20 至+12mV。我们观察到,PEG 化阳离子脂质体的 D 值(1.14μm/s)明显低于 PEG 化中性和阴离子脂质体(2.78 和 2.87μm/s)。然而,PEG 化阳离子脂质体在玻璃体内的分布与其他系统相似。这些结果表明,具有有限正电荷的 PEG 化阳离子脂质体可以扩散穿过玻璃体,表明玻璃体作为纳米载体的屏障(Ø<500nm)比之前认为的仅仅是静电屏障更为复杂。

相似文献

1
The diffusion dynamics of PEGylated liposomes in the intact vitreous of the ex vivo porcine eye: A fluorescence correlation spectroscopy and biodistribution study.PEG 化脂质体在体外猪眼完整玻璃体中的扩散动力学:荧光相关光谱和生物分布研究。
Int J Pharm. 2017 Apr 30;522(1-2):90-97. doi: 10.1016/j.ijpharm.2017.03.003. Epub 2017 Mar 4.
2
Diffusion and Protein Corona Formation of Lipid-Based Nanoparticles in the Vitreous Humor: Profiling and Pharmacokinetic Considerations.脂质纳米粒子在玻璃体液中的扩散和蛋白冠形成:分析和药代动力学考虑。
Mol Pharm. 2021 Feb 1;18(2):699-713. doi: 10.1021/acs.molpharmaceut.0c00411. Epub 2020 Jul 8.
3
Sustaining Intravitreal Residence With L-Arginine Peptide-Conjugated Nanocarriers.用L-精氨酸肽共轭纳米载体维持玻璃体内驻留
Invest Ophthalmol Vis Sci. 2017 Oct 1;58(12):5142-5150. doi: 10.1167/iovs.17-22160.
4
Skin Transport of Hydrophilic Compound-Loaded PEGylated Lipid Nanocarriers: Comparative Study of Liposomes, Niosomes, and Solid Lipid Nanoparticles.负载亲水性化合物的聚乙二醇化脂质纳米载体的皮肤转运:脂质体、非离子表面活性剂囊泡和固体脂质纳米粒的比较研究
Biol Pharm Bull. 2016;39(8):1254-62. doi: 10.1248/bpb.b15-00981.
5
Polyborane-encapsulated PEGylated Liposomes Prepared Using Post-insertion Technique for Boron Neutron Capture Therapy.采用后插入技术制备的用于硼中子俘获治疗的聚硼烷包封聚乙二醇化脂质体。
J Oleo Sci. 2019;68(12):1261-1270. doi: 10.5650/jos.ess19218.
6
Sequential treatment of oxaliplatin-containing PEGylated liposome together with S-1 improves intratumor distribution of subsequent doses of oxaliplatin-containing PEGylated liposome.奥沙利铂-聚乙二醇脂质体序贯联合替吉奥胶囊治疗可提高后续奥沙利铂-聚乙二醇脂质体瘤内分布。
Eur J Pharm Biopharm. 2014 May;87(1):142-51. doi: 10.1016/j.ejpb.2013.12.007. Epub 2013 Dec 17.
7
Wanted and unwanted properties of surface PEGylated nucleic acid nanoparticles in ocular gene transfer.眼部基因传递中表面聚乙二醇化核酸纳米颗粒的有利和不利特性
J Control Release. 2007 Oct 8;122(3):226-35. doi: 10.1016/j.jconrel.2007.05.004. Epub 2007 May 13.
8
Revealing Dynamics of Accumulation of Systemically Injected Liposomes in the Skin by Intravital Microscopy.活体显微镜观察系统性注射脂质体在皮肤中的积累动态。
ACS Nano. 2017 Nov 28;11(11):11584-11593. doi: 10.1021/acsnano.7b06524. Epub 2017 Oct 18.
9
Mucoadhesive maleimide-functionalised liposomes for drug delivery to urinary bladder.用于向膀胱递药的黏附性马来酰亚胺功能化脂质体。
Eur J Pharm Sci. 2018 Jan 1;111:83-90. doi: 10.1016/j.ejps.2017.09.039. Epub 2017 Sep 27.
10
PEGylated synthetic surfactant vesicles (Niosomes): novel carriers for oligonucleotides.聚乙二醇化合成表面活性剂囊泡(非离子表面活性剂囊泡):用于寡核苷酸的新型载体。
J Mater Sci Mater Med. 2008 Feb;19(2):607-14. doi: 10.1007/s10856-007-3193-4. Epub 2007 Jul 10.

引用本文的文献

1
Active Transport and Ocular Distribution of Intravitreally Injected Liposomes.主动转运与玻璃体内注射脂质体的眼内分布。
Transl Vis Sci Technol. 2023 Aug 1;12(8):20. doi: 10.1167/tvst.12.8.20.
2
Optimization of an Injectable Hydrogel Depot System for the Controlled Release of Retinal-Targeted Hybrid Nanoparticles.用于视网膜靶向杂化纳米颗粒控释的可注射水凝胶储库系统的优化
Pharmaceutics. 2022 Dec 21;15(1):25. doi: 10.3390/pharmaceutics15010025.
3
Model Systems for Studies Into Retinal Neuroprotection.视网膜神经保护研究的模型系统
Front Neurosci. 2022 Jul 7;16:938089. doi: 10.3389/fnins.2022.938089. eCollection 2022.
4
Lipid Nanoparticles as a Promising Drug Delivery Carrier for Topical Ocular Therapy-An Overview on Recent Advances.脂质纳米颗粒作为用于局部眼部治疗的有前景的药物递送载体——近期进展综述
Pharmaceutics. 2022 Feb 27;14(3):533. doi: 10.3390/pharmaceutics14030533.
5
Application of an organotypic ocular perfusion model to assess intravitreal drug distribution in human and animal eyes.应用器官型眼灌注模型评估人眼和动物眼中的玻璃体内药物分布。
J R Soc Interface. 2022 Jan;19(186):20210734. doi: 10.1098/rsif.2021.0734. Epub 2022 Jan 26.
6
Investigating Ex Vivo Animal Models to Test the Performance of Intravitreal Liposomal Drug Delivery Systems.研究用于测试玻璃体内脂质体药物递送系统性能的离体动物模型。
Pharmaceutics. 2021 Jul 2;13(7):1013. doi: 10.3390/pharmaceutics13071013.
7
Advanced Static and Dynamic Fluorescence Microscopy Techniques to Investigate Drug Delivery Systems.用于研究药物递送系统的先进静态和动态荧光显微镜技术
Pharmaceutics. 2021 Jun 11;13(6):861. doi: 10.3390/pharmaceutics13060861.
8
Degradation of Drug Delivery Nanocarriers and Payload Release: A Review of Physical Methods for Tracing Nanocarrier Biological Fate.药物递送纳米载体的降解与载药量释放:纳米载体生物学命运追踪物理方法综述
Pharmaceutics. 2021 May 21;13(6):770. doi: 10.3390/pharmaceutics13060770.
9
siRNA Therapeutics in Ocular Diseases.siRNA 治疗在眼部疾病中的应用
Methods Mol Biol. 2021;2282:417-442. doi: 10.1007/978-1-0716-1298-9_23.
10
The role of cGMP-signalling and calcium-signalling in photoreceptor cell death: perspectives for therapy development.环鸟苷酸信号和钙信号在光感受器细胞死亡中的作用:治疗开发的新视角。
Pflugers Arch. 2021 Sep;473(9):1411-1421. doi: 10.1007/s00424-021-02556-9. Epub 2021 Apr 16.